Wall Street analyst updates UnitedHealth stock after Buffett's $1.6 billion stake

Group 1 - Bank of America Securities has updated its outlook on UnitedHealth Group, maintaining a 'Neutral' rating while raising its price target to $325 from $290, reflecting a potential upside of nearly 7% from the current price of $304 [1] - The upward revision follows Berkshire Hathaway's recent $1.6 billion investment in UnitedHealth, which reaffirms market confidence in the healthcare giant [3] - Analysts see a potential earnings recovery in 2027, which could unlock additional upside for UnitedHealth [3] Group 2 - Despite the higher target, Bank of America remains cautious due to limited near-term earnings visibility and unresolved key uncertainties, which could lead to another 12 months of underperformance [4] - The company has faced leadership changes, suspended financial guidance, and federal probes into its Medicare Advantage billing practices, contributing to significant stock sell-offs [5] - UnitedHealth remains the largest Medicare Advantage provider with over 8 million members, while its Optum unit continues to expand in care and technology services [6]